The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
Official Title: Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Adults Aged 18 Years and Older With Haematologic Malignancies
Study ID: NCT01767467
Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of GSK Biologicals' vaccine GSK1437173A in subjects aged 18 years and older with blood cancers. The study will evaluate safety-related events and antibody and cellular immune responses to the study vaccine, as compared to placebo.
Detailed Description: Amendment to protocol posting: Increase in sample size, update of country/region-specific information (Sections 5, 6 and 9). Promotion of secondary to primary objective; related update of primary and secondary outcome measures (Sections 4 and 7).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
GSK Investigational Site, Inverness, Florida, United States
GSK Investigational Site, Chicago, Illinois, United States
GSK Investigational Site, Elkhart, Indiana, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Minneapolis, Minnesota, United States
GSK Investigational Site, Chapel Hill, North Carolina, United States
GSK Investigational Site, Seattle, Washington, United States
GSK Investigational Site, Marshfield, Wisconsin, United States
GSK Investigational Site, Darlinghurst, New South Wales, Australia
GSK Investigational Site, Hobart, Tasmania, Australia
GSK Investigational Site, Coburg, Victoria, Australia
GSK Investigational Site, Wodonga, Victoria, Australia
GSK Investigational Site, Antwerpen, , Belgium
GSK Investigational Site, Brugge, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Hasselt, , Belgium
GSK Investigational Site, Jette, , Belgium
GSK Investigational Site, Leuven, , Belgium
GSK Investigational Site, Saint John, New Brunswick, Canada
GSK Investigational Site, Halifax, Nova Scotia, Canada
GSK Investigational Site, Oshawa, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Praha 2, , Czechia
GSK Investigational Site, Helsinki, , Finland
GSK Investigational Site, Tampere, , Finland
GSK Investigational Site, Montpellier cedex 5, , France
GSK Investigational Site, Mulhouse, , France
GSK Investigational Site, Nantes cedex 1, , France
GSK Investigational Site, Pessac cedex, , France
GSK Investigational Site, Périgueux cedex, , France
GSK Investigational Site, Rouen cedex 1, , France
GSK Investigational Site, Hong Kong, , Hong Kong
GSK Investigational Site, Meldola (FC), Emilia-Romagna, Italy
GSK Investigational Site, Udine, Friuli-Venezia-Giulia, Italy
GSK Investigational Site, Novara, Piemonte, Italy
GSK Investigational Site, Busan, , Korea, Republic of
GSK Investigational Site, Daegu, , Korea, Republic of
GSK Investigational Site, Incheon, , Korea, Republic of
GSK Investigational Site, Jellanamdo, , Korea, Republic of
GSK Investigational Site, Jeonju, , Korea, Republic of
GSK Investigational Site, Kyunggi-do, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Christchurch, , New Zealand
GSK Investigational Site, Hamilton, , New Zealand
GSK Investigational Site, Lahore, , Pakistan
GSK Investigational Site, Multan, , Pakistan
GSK Investigational Site, Panama, , Panama
GSK Investigational Site, Chorzow, , Poland
GSK Investigational Site, Opole, , Poland
GSK Investigational Site, Slupsk, , Poland
GSK Investigational Site, Ekaterinburg, , Russian Federation
GSK Investigational Site, Nizhniy Novgorod, , Russian Federation
GSK Investigational Site, Petrozavodsk, , Russian Federation
GSK Investigational Site, St'Petersburg, , Russian Federation
GSK Investigational Site, St-Petersburg, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Móstoles, Madrid, Spain
GSK Investigational Site, Barcelona, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Majadahonda (Madrid), , Spain
GSK Investigational Site, Pozuelo De Alarcón/Madrid, , Spain
GSK Investigational Site, Santander, , Spain
GSK Investigational Site, Eskilstuna, , Sweden
GSK Investigational Site, Karlskrona, , Sweden
GSK Investigational Site, Malmö, , Sweden
GSK Investigational Site, Uppsala, , Sweden
GSK Investigational Site, Kaohsiung, , Taiwan
GSK Investigational Site, Taichung, , Taiwan
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taoyuan Hsien, , Taiwan
GSK Investigational Site, Ankara, , Turkey
GSK Investigational Site, Ankara, , Turkey
GSK Investigational Site, Orpington, Kent, United Kingdom
GSK Investigational Site, Airdrie, Lanarkshire, United Kingdom
GSK Investigational Site, Swindon, Wiltshire, United Kingdom
GSK Investigational Site, Bournemouth, , United Kingdom
GSK Investigational Site, Headington, Oxford, , United Kingdom
GSK Investigational Site, London, , United Kingdom
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR